MétaCan
Menu
Back to cohort
Record W4392058510 · doi:10.32920/25262752.v1

The Development of Theranostic Agents for Photoacoustic Detection and Laser-activated Anti-HER2 Breast Cancer Therapy

2024· preprint· en· W4392058510 on OpenAlexafffund
Yan Jie Wang

Bibliographic record

Venuenot available
Typepreprint
Languageen
FieldEngineering
TopicNanoplatforms for cancer theranostics
Canadian institutionsToronto Metropolitan University
FundersCanadian Institutes of Health ResearchChongqing Medical UniversityOntario Ministry of Research and InnovationNatural Sciences and Engineering Research Council of CanadaCanada Research Chairs
KeywordsBreast cancerCancer researchMolecular imagingCancerDrug deliveryMaterials scienceBiomedical engineeringBiocompatibilityMedicineIn vivoNanotechnologyOncologyInternal medicine

Abstract

fetched live from OpenAlex

Breast cancer is one of the most common malignancies among women. Mammography and ultrasound imaging modalities are routinely used as breast cancer screening procedures. The sensitivity of those modalities decreases significantly in patients with dense tissues and advanced stage breast cancer. Photoacoustic (PA) imaging, as a non-invasive modality, may offer increased sensitivity for screening breast tumors. To probe additional, specific structural and molecular information, targeted exogenous contrast agents are often introduced. Gold nanorods (GNRs) are effective contrast agents in PA imaging due to their high optical absorption at the near-infrared band and superior biocompatibility. The high spatial localization of GNRs provides significant increases in signal amplitude within the target tissue and assists nanoparticle-mediated cancer therapy. I proposed using targeted theranostic agents containing GNRs for breast tumour detection using a photoacoustic method and laser-activated therapy. In this work, I have developed polymeric nanoparticles (NPs) for the imaging and treatment of breast cancer over-expressing human epidermal growth factor receptor 2 (HER2). These NPs contain a perfluorohexane liquid and gold nanorods (GNRs) interior stabilized by biodegradable and biocompatible copolymer PLGA-PEG. Water-insoluble therapeutic drug Paclitaxel (PAC) and fluorescent dye are encapsulated into the PLGA shell. The NP surfaces are conjugated to the HER2-binding antibody Herceptin to target HER2-positive cancer cells actively. The NP uptake by tumor is evaluated using multi-spectral PA imaging. The effectiveness of cancer cell treatment by laser-induced particle vaporization and stimulated drug release are investigated in vitro. The therapeutic efficacy on tumours is also performed using a xenograft mouse bilateral tumor model. PA quantitative analysis demonstrates that these NPs actively target HER2 positive cells with high efficiency. The laser-induced vaporization causes more damage to the targeted cells versus PAC-only and negative controls. The relative concentrations of GNRs in the tumour with peak signal at 6 hours are quantified using a linear spectral unmixing technique. The therapeutic efficacy of these nanoparticles is evaluated using tissue immunofluorescence and histology. In this dissertation, PLGA-PEG-GNRs as theranostic agents for anti-HER2 breast cancer therapy are developed. They may provide better diagnostic imaging and therapeutic potential than current methods for treating HER2-positive breast cancer.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.254
Teacher spread0.236 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes2
Has abstractyes

Explore more

Same topicNanoplatforms for cancer theranosticsFrench-language works237,207